Veronesi Maria Cristina, Rota Alessandro, Battocchio Massimiliano, Faustini Massimo, Mollo Antonio
Department of Clinical Veterinary Science, Division of Obstetrics and Gynaecology, Veterinary Faculty, University of Milan, Via Celoria, 10-20133 Milan, Italy.
Acta Vet Hung. 2009 Mar;57(1):171-82. doi: 10.1556/AVet.57.2009.1.17.
Some aspects of spaying-related urinary incontinence in the bitch still remain incompletely clarified. Therefore, the aims of the present study were to evaluate the prevalence of the disease among spayed dogs, to detect differences in risk related to the type of surgery, to describe the characteristics of incontinent bitches, to assess the influence of age at surgery on the onset of incontinence occurrence, and to assess the effectiveness and long-term side effects of oestrogen therapy in affected bitches. Among 750 bitches submitted to ovariectomy or ovariohysterectomy, those showing spaying-related urinary incontinence were evaluated. Oestrogen replacement therapy consisted of administering an effective dose followed by an individual maintenance dose. The results showed that the disease occurred in 5% of neutered bitches, the type of surgery did not affect the disease occurrence, affected bitches frequently represented large or giant breeds or large-size mongrels, the body weight of the affected bitches at surgery was often > 20 kg, the disease seems to be associated with tail docking, the age at surgery influences the onset ofincontinence, with earlier occurrence in older bitches, and that a strong co-operation between owners and veterinarians is necessary to achieve successful response to oestrogen replacement therapy. Long-term administration seems to be unrelated to oestrogenic side effects.
母犬绝育相关的尿失禁的某些方面仍未完全阐明。因此,本研究的目的是评估绝育犬中该病的患病率,检测与手术类型相关的风险差异,描述尿失禁母犬的特征,评估手术时年龄对尿失禁发生的影响,并评估雌激素疗法对患病母犬的有效性和长期副作用。在750只接受卵巢切除术或子宫卵巢切除术的母犬中,对那些表现出绝育相关尿失禁的母犬进行了评估。雌激素替代疗法包括先给予有效剂量,然后给予个体维持剂量。结果显示,该病发生在5%的绝育母犬中,手术类型不影响该病的发生,患病母犬通常为大型或巨型犬种或大型杂种犬,手术时患病母犬的体重通常>20kg,该病似乎与断尾有关,手术时的年龄影响尿失禁的发生,老年母犬发病较早,并且主人和兽医之间的密切合作对于雌激素替代疗法取得成功反应是必要的。长期给药似乎与雌激素副作用无关。